📣 VC round data is live. Check it out!

Vystar Valuation Multiples

Discover revenue and EBITDA valuation multiples for Vystar and similar public comparables like POLYDUCT Plastic, Trinseo, Sansuy Industria, Svenska Aerogel and more.

Vystar Overview

About Vystar

Vystar Corp is engaged in the rubber and plastic products market. It develops technology to produce Vytex Natural Rubber Latex which reduces antigenic protein and non-rubbers in natural rubber latex to undetectable levels. The company's products and services include Natural Rubber Latex and clinical sleep diagnostics and durable medical equipment. The company derives revenue from sales of or license fees of Vytex NRL raw material to manufacturers and distributors of rubber and rubber end products.


Founded

2003

HQ

United States

Employees

1

Website

vytex.com

Financials (FY)

Revenue:
Net Income:

EV

$5M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Vystar Stock Performance

Vystar has current market cap of $4M, and enterprise value of $5M.


Vystar's stock price is $0.14.

See more trading valuation data for Vystar
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$5M$4M0.0%

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Vystar Valuation Multiples

Vystar Financial Valuation Multiples

As of May 14, 2026, Vystar has market cap of $4M and EV of $5M.

202320242025202620272028
EV/FCF(10.3x)(45.5x)(25.2x)

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Vystar Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Vystar Margins & Growth Rates

See estimated margins and future growth rates for Vystar

Vystar Growth Rates

23/2424/2526/2727/2828/29
FCF Growth(77%)80%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Vystar Competitors

Vystar competitors include POLYDUCT Plastic, Trinseo, Sansuy Industria, Svenska Aerogel, Prebona, Cyclezyme, Highlander Enterprise, Soprocal Calerias, EcoRub and Australian Silica Quartz.

Most Vystar public comparables operate across Chemicals, Advanced Materials and DeepTech.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
POLYDUCT Plastic0.2x1.9x
Trinseo0.9x16.8x
Sansuy Industria0.3x186.7x
Svenska Aerogel5.9x(1.2x)
Prebona13.8x(8.6x)
Cyclezyme40.3x(22.8x)
Highlander Enterprise32.2x42.0x
Soprocal Calerias0.2x(2.5x)

This data is available for Pro users. Sign up to see all Vystar competitors and their valuation data.

Start Free Trial

Vystar M&A Activity

Vystar has acquired 2 companies to date.

Last acquisition by Vystar was on May 28th 2019. Vystar acquired Fluid Energy Conversion for undisclosed valuation.

See M&A valuation multiples

Latest Acquisitions by Vystar

Fluid Energy Conversion
NHS Holdings
Description
Fluid Energy Conversion is a U.S.-based green technology company utilizing patented acoustic systems to convert sound energy for industrial applications. Their devices apply ultrasonic waves to disinfect water, enhance irrigation efficiency, and accelerate chemical processes in wastewater treatment. Headquartered in Boulder, Colorado, the firm targets municipal utilities and agriculture with scalable reactors deployed in North America.
NHS Holdings is the exclusive U.S. distributor of Vytex natural rubber latex foam produced by Vystar Corporation for manufacturers in bedding, footwear, and medical applications. Based in Georgia, the company facilitates supply of this low-protein, hypoallergenic latex alternative to major producers seeking sustainable, non-sensitizing materials. Vytex foam reduces antigenic proteins by over 90 percent compared to standard latex, serving markets that prioritize allergen-free products.
HQ CountryUnited StatesUnited States
HQ City
Palm Springs, CA
Wilmington, DE
Deal Date28 May 20199 Jan 2018
Valuationundisclosed$1M
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Vystar acquisitions and their M&A valuation multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Vystar

When was Vystar founded?Vystar was founded in 2003.
Where is Vystar headquartered?Vystar is headquartered in United States.
How many employees does Vystar have?As of today, Vystar has over 1 employees.
Is Vystar publicly listed?Yes, Vystar is a public company listed on OTC Pink Sheets.
What is the stock symbol of Vystar?Vystar trades under VYST ticker.
When did Vystar go public?Vystar went public in 2009.
Who are competitors of Vystar?Vystar main competitors include POLYDUCT Plastic, Trinseo, Sansuy Industria, Svenska Aerogel, Prebona, Cyclezyme, Highlander Enterprise, Soprocal Calerias, EcoRub, Australian Silica Quartz.
What is the current market cap of Vystar?Vystar's current market cap is $4M.
Is Vystar profitable?No, Vystar is not profitable.
How many companies Vystar has acquired to date?As of May 2026, Vystar has acquired 2 companies.
What was the largest acquisition by Vystar?$1M acquisition of NHS Holdings on 9th January 2018 was the largest M&A Vystar has done to date.
What companies Vystar acquired?Vystar acquired NHS Holdings and Fluid Energy Conversion.
In how many companies Vystar has invested to date?Vystar hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Vystar

Lists including Vystar

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial